HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Adkins, A. Articles by Rizza, R. Search for Related Content PubMed PubMed Citation Articles by Adkins, A. Articles by Rizza, R. Social Bookmarking                What's this?

Higher Insulin Concentrations Are Required to Suppress Gluconeogenesis Than Glycogenolysis in Nondiabetic Humans

From the Endocrine Research Unit, Mayo Foundation, Rochester, Minnesota

To determine the mechanism(s) by which insulin inhibits endogenous glucose production (EGP) in nondiabetic humans, insulin was infused at rates of 0.25, 0.375, or 0.5 mU · kg^-1 · min^-1 and glucose was clamped at 5.5 mmol/l. EGP, gluconeogenesis, and uridine-diphosphoglucose (UDP)-glucose flux were measured using [3-³H]glucose, deuterated water, and the acetaminophen glucuronide methods, respectively. An increase in insulin from 75 to 100 to 150 pmol/l (12.5 to 17 to 25 µU/ml) resulted in progressive (ANOVA; P < 0.02) suppression of EGP (13.1 ± 1.3 vs. 11.7 ± 1.03 vs. 6.4 ± 2.15 µmol · kg^-1 · min^-1) that was entirely due to a progressive decrease (ANOVA; P < 0.05) in the contribution of glycogenolysis to EGP (4.7 ± 1.7 vs. 3.4 ± 1.2 vs. –2.1 ± 1.3 µmol · kg^-1 · min^-1). In contrast, both the contribution of gluconeogenesis to EGP (8.4 ± 1.0 vs. 8.3 ± 1.1 vs. 8.5 ± 1.3 µmol · kg^-1 · min^-1) and UDP-glucose flux (5.0 ± 0.4 vs. 5.0 ± 0.3 vs. 4.0 ± 0.5 µmol · kg^-1 · min^-1) remained unchanged. The contribution of the direct (extracellular) pathway to UDP-glucose flux was minimal and constant during all insulin infusions. We conclude that higher insulin concentrations are required to suppress the contribution of gluconeogenesis of EGP than are required to suppress the contribution of glycogenolysis to EGP in healthy nondiabetic humans. Since suppression of glycogenolysis occurred without a decrease in UDP-glucose flux, this implies that insulin inhibits EGP, at least in part, by directing glucose-6-phosphate into glycogen rather than through the glucose-6-phosphatase pathway.

CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				R. Basu, V. Chandramouli, B. Dicke, B. R. Landau, and R. A. Rizza Plasma C5 Glucose-to-2H2O Ratio Does Not Provide an Accurate Assessment of Gluconeogenesis During Hyperinsulinemic-Euglycemic Clamps in Either Nondiabetic or Diabetic Humans Diabetes, July 1, 2008; 57(7): 1800 - 1804. [Abstract] [Full Text] [PDF]

				G. Bock, W. C. Schumann, R. Basu, S. C. Burgess, Z. Yan, V. Chandramouli, R. A. Rizza, and B. R. Landau Evidence That Processes Other Than Gluconeogenesis May Influence the Ratio of Deuterium on the Fifth and Third Carbons of Glucose: Implications for the Use of 2H2O to Measure Gluconeogenesis in Humans Diabetes, January 1, 2008; 57(1): 50 - 55. [Abstract] [Full Text] [PDF]

				G. Bock, E. Chittilapilly, R. Basu, G. Toffolo, C. Cobelli, V. Chandramouli, B. R. Landau, and R. A. Rizza Contribution of Hepatic and Extrahepatic Insulin Resistance to the Pathogenesis of Impaired Fasting Glucose: Role of Increased Rates of Gluconeogenesis Diabetes, June 1, 2007; 56(6): 1703 - 1711. [Abstract] [Full Text] [PDF]

				P. Staehr, O. Hother-Nielsen, H. Beck-Nielsen, M. Roden, H. Stingl, J. J. Holst, P. K. Jones, V. Chandramouli, and B. R. Landau Hepatic autoregulation: response of glucose production and gluconeogenesis to increased glycogenolysis Am J Physiol Endocrinol Metab, May 1, 2007; 292(5): E1265 - E1269. [Abstract] [Full Text] [PDF]

				G. Bock, C. Dalla Man, M. Campioni, E. Chittilapilly, R. Basu, G. Toffolo, C. Cobelli, and R. Rizza Effects of Nonglucose Nutrients on Insulin Secretion and Action in People With Pre-Diabetes Diabetes, April 1, 2007; 56(4): 1113 - 1119. [Abstract] [Full Text] [PDF]

				G. Allick, S. N. van der Crabben, M. T. Ackermans, E. Endert, and H. P. Sauerwein Measurement of gluconeogenesis by deuterated water: the effect of equilibration time and fasting period Am J Physiol Endocrinol Metab, June 1, 2006; 290(6): E1212 - E1217. [Abstract] [Full Text] [PDF]

				H. J. Woerle, E. Szoke, C. Meyer, J. M. Dostou, S. D. Wittlin, N. R. Gosmanov, S. L. Welle, and J. E. Gerich Mechanisms for abnormal postprandial glucose metabolism in type 2 diabetes Am J Physiol Endocrinol Metab, January 1, 2006; 290(1): E67 - E77. [Abstract] [Full Text] [PDF]

				C. Meyer, P. Saar, N. Soydan, M. Eckhard, R. G. Bretzel, J. Gerich, and T. Linn A Potential Important Role of Skeletal Muscle in Human Counterregulation of Hypoglycemia J. Clin. Endocrinol. Metab., November 1, 2005; 90(11): 6244 - 6250. [Abstract] [Full Text] [PDF]

				R. Basu, V. Chandramouli, B. Dicke, B. Landau, and R. Rizza Obesity and Type 2 Diabetes Impair Insulin-Induced Suppression of Glycogenolysis as Well as Gluconeogenesis Diabetes, July 1, 2005; 54(7): 1942 - 1948. [Abstract] [Full Text] [PDF]

				R. Basu, A. Basu, C. M. Johnson, W. F. Schwenk, and R. A. Rizza Insulin Dose-Response Curves for Stimulation of Splanchnic Glucose Uptake and Suppression of Endogenous Glucose Production Differ in Nondiabetic Humans and Are Abnormal in People With Type 2 Diabetes Diabetes, August 1, 2004; 53(8): 2042 - 2050. [Abstract] [Full Text] [PDF]

				R. Basu, W. F. Schwenk, and R. A. Rizza Both fasting glucose production and disappearance are abnormal in people with "mild" and "severe" type 2 diabetes Am J Physiol Endocrinol Metab, July 1, 2004; 287(1): E55 - E62. [Abstract] [Full Text] [PDF]